Page last updated: 2024-08-17

bromodeoxyuridine and Hypertrophy, Right Ventricular

bromodeoxyuridine has been researched along with Hypertrophy, Right Ventricular in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bloch, KD; Brouckaert, P; Buys, E; Collen, D; Dewerchin, M; Gillijns, H; Graveline, A; Ichinose, F; Janssens, S; Marsboom, G; Pellens, M; Pokreisz, P; Sips, P; Swinnen, M; Vermeersch, P1

Other Studies

1 other study(ies) available for bromodeoxyuridine and Hypertrophy, Right Ventricular

ArticleYear
Soluble guanylate cyclase-alpha1 deficiency selectively inhibits the pulmonary vasodilator response to nitric oxide and increases the pulmonary vascular remodeling response to chronic hypoxia.
    Circulation, 2007, Aug-21, Volume: 116, Issue:8

    Topics: Acute Disease; Animals; Antimetabolites; Blood Pressure; Bromodeoxyuridine; Chronic Disease; Cyclic GMP; Dimerization; Female; Guanylate Cyclase; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Male; Mice; Mice, Mutant Strains; Nitric Oxide; Pulmonary Artery; Pulmonary Circulation; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase; Vasodilation; Ventricular Function, Right

2007